当前位置:
X-MOL 学术
›
Biochem. J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Filamin A regulates platelet shape change and contractile force generation via phosphorylation of the myosin light chain.
Biochemical Journal ( IF 4.4 ) Pub Date : 2024-10-17 , DOI: 10.1042/bcj20240114 Hugh Kim 1 , Felix Hong 2 , Molly Y Mollica 3 , Kalyan Golla 1 , Enoli De Silva 1 , Nathan J Sniadecki 4 , José A López 5
Biochemical Journal ( IF 4.4 ) Pub Date : 2024-10-17 , DOI: 10.1042/bcj20240114 Hugh Kim 1 , Felix Hong 2 , Molly Y Mollica 3 , Kalyan Golla 1 , Enoli De Silva 1 , Nathan J Sniadecki 4 , José A López 5
Affiliation
Platelets are critical mediators of hemostasis and thrombosis. Platelets circulate as discs in their resting form but change shape rapidly upon activation by vascular damage and/or soluble agonists such as thrombin. Platelet shape change is driven by a dynamic remodeling of the actin cytoskeleton. Actin filaments interact with the protein myosin, which is phosphorylated on the myosin light chain (MLC) upon platelet activation. Actin-myosin interactions trigger contraction of the actin cytoskeleton, which drives platelet spreading and contractile force generation. Filamin A (FLNA) is an actin cross-linking protein that stabilizes the attachment between subcortical actin filaments and the cell membrane. In addition, FLNA binds multiple proteins and serves as a critical intracellular signaling scaffold. Here, we used platelets from mice with a megakaryocyte/platelet-specific deletion of FLNA to investigate the role of FLNA in regulating platelet shape change. Relative to controls, FLNA-null platelets exhibited defects in stress fiber formation, contractile force generation, and MLC phosphorylation in response to thrombin stimulation. Blockade of Rho kinase (ROCK) and protein kinase C (PKC) with the inhibitors Y27632 and bisindolylmaleimide (BIM), respectively, also attenuated MLC phosphorylation; our data further indicate that ROCK and PKC promote MLC phosphorylation through independent pathways. Notably, the activity of both ROCK and PKC was diminished in the FLNA-deficient platelets. We conclude that FLNA regulates thrombin-induced MLC phosphorylation and platelet contraction, in a ROCK- and PKC-dependent manner.
中文翻译:
细丝蛋白 A 通过肌球蛋白轻链的磷酸化调节血小板形状变化和收缩力的产生。
血小板是止血和血栓形成的关键介质。血小板以静息形式以椎间盘的形式循环,但在被血管损伤和/或可溶性激动剂(如凝血酶)激活后迅速改变形状。血小板形状的变化是由肌动蛋白细胞骨架的动态重塑驱动的。肌动蛋白丝与肌球蛋白相互作用,肌球蛋白在血小板激活时在肌球蛋白轻链 (MLC) 上被磷酸化。肌动蛋白-肌球蛋白相互作用触发肌动蛋白细胞骨架的收缩,从而驱动血小板扩散和收缩力的产生。细丝蛋白 A (FLNA) 是一种肌动蛋白交联蛋白,可稳定皮质下肌动蛋白丝与细胞膜之间的附着。此外,FLNA 结合多种蛋白质,并作为关键的细胞内信号转导支架。在这里,我们使用来自 FLNA 巨核细胞/血小板特异性缺失的小鼠的血小板来研究 FLNA 在调节血小板形状变化中的作用。相对于对照组,FLNA 缺失血小板在凝血酶刺激下表现出应力纤维形成、收缩力产生和 MLC 磷酸化缺陷。分别用抑制剂 Y27632 和双吲哚基马来酰亚胺 (BIM) 阻断 Rho 激酶 (ROCK) 和蛋白激酶 C (PKC) 也减弱了 MLC 磷酸化;我们的数据进一步表明,ROCK 和 PKC 通过独立途径促进 MLC 磷酸化。值得注意的是,在 FLNA 缺陷血小板中,ROCK 和 PKC 的活性均减弱。我们得出结论,FLNA 以 ROCK 和 PKC 依赖性方式调节凝血酶诱导的 MLC 磷酸化和血小板收缩。
更新日期:2024-08-27
中文翻译:
细丝蛋白 A 通过肌球蛋白轻链的磷酸化调节血小板形状变化和收缩力的产生。
血小板是止血和血栓形成的关键介质。血小板以静息形式以椎间盘的形式循环,但在被血管损伤和/或可溶性激动剂(如凝血酶)激活后迅速改变形状。血小板形状的变化是由肌动蛋白细胞骨架的动态重塑驱动的。肌动蛋白丝与肌球蛋白相互作用,肌球蛋白在血小板激活时在肌球蛋白轻链 (MLC) 上被磷酸化。肌动蛋白-肌球蛋白相互作用触发肌动蛋白细胞骨架的收缩,从而驱动血小板扩散和收缩力的产生。细丝蛋白 A (FLNA) 是一种肌动蛋白交联蛋白,可稳定皮质下肌动蛋白丝与细胞膜之间的附着。此外,FLNA 结合多种蛋白质,并作为关键的细胞内信号转导支架。在这里,我们使用来自 FLNA 巨核细胞/血小板特异性缺失的小鼠的血小板来研究 FLNA 在调节血小板形状变化中的作用。相对于对照组,FLNA 缺失血小板在凝血酶刺激下表现出应力纤维形成、收缩力产生和 MLC 磷酸化缺陷。分别用抑制剂 Y27632 和双吲哚基马来酰亚胺 (BIM) 阻断 Rho 激酶 (ROCK) 和蛋白激酶 C (PKC) 也减弱了 MLC 磷酸化;我们的数据进一步表明,ROCK 和 PKC 通过独立途径促进 MLC 磷酸化。值得注意的是,在 FLNA 缺陷血小板中,ROCK 和 PKC 的活性均减弱。我们得出结论,FLNA 以 ROCK 和 PKC 依赖性方式调节凝血酶诱导的 MLC 磷酸化和血小板收缩。